INTERMACS profiles of advanced heart failure: the current picture
- PMID: 19481012
- DOI: 10.1016/j.healun.2009.02.015
INTERMACS profiles of advanced heart failure: the current picture
Abstract
Background: The current classification of patients with New York Heart Association Class IV symptoms does not offer adequate description to allow optimal selection of patients for the current options of medical and pacing therapies, cardiac transplantation and mechanical circulatory support.
Methods: Seven clinical profiles and an arrhythmia modifier were developed and implemented into the first year of data collection for the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). The INTERMACS Coordinators' Council provided ongoing feedback regarding the characterization of patients receiving implantable devices.
Results: The definition of 7 clinical profiles revealed that 80% of current devices are being used in the 2 profiles with the highest levels of clinical compromise. The INTERMACS Coordinators' Council helped to identify gaps in the characterization of hospitalized patients on temporary assist devices and of homebound patients with resting symptoms, which has led to revised definitions of Profile 3 and 4 and the addition of 2 new modifiers, for temporary circulatory support devices in the hospital, and for frequent rehospitalization of patients at home.
Conclusions: Patients considered for mechanical circulatory support can now be classified using the 7 profiles plus 3 modifiers developed through INTERMACS. Further understanding these profiles and their impact on outcome should help to better select patients and therapies in the advanced stages of disease.
Similar articles
-
Preoperative INTERMACS profiles determine postoperative outcomes in critically ill patients undergoing emergency heart transplantation: analysis of the Spanish National Heart Transplant Registry.Circ Heart Fail. 2013 Jul;6(4):763-72. doi: 10.1161/CIRCHEARTFAILURE.112.000237. Epub 2013 May 14. Circ Heart Fail. 2013. PMID: 23674362
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States.Ann Thorac Surg. 2012 Dec;94(6):2147-58. doi: 10.1016/j.athoracsur.2012.09.040. Epub 2012 Nov 12. Ann Thorac Surg. 2012. PMID: 23153481 Review.
-
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary.Circ Heart Fail. 2013 Jan;6(1):145-50. doi: 10.1161/HHF.0b013e318279f55d. Epub 2012 Nov 12. Circ Heart Fail. 2013. PMID: 23149496 Review.
-
Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.J Heart Lung Transplant. 2009 Aug;28(8):827-33. doi: 10.1016/j.healun.2009.04.033. J Heart Lung Transplant. 2009. PMID: 19632580
-
INTERMACS: interval analysis of registry data.J Am Coll Surg. 2009 May;208(5):755-61; discussion 761-2. doi: 10.1016/j.jamcollsurg.2008.11.016. Epub 2009 Feb 1. J Am Coll Surg. 2009. PMID: 19476831
Cited by
-
Adverse Events in Total Artificial Heart for End-Stage Heart Failure: Insight From the Food and Drug Administration Manufacturer and User Facility Device Experience (MAUDE).Int J Heart Fail. 2023 Sep 18;6(2):76-81. doi: 10.36628/ijhf.2023.0020. eCollection 2024 Apr. Int J Heart Fail. 2023. PMID: 38694934 Free PMC article.
-
Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation.Am Heart J Plus. 2022 Dec 5;24:100233. doi: 10.1016/j.ahjo.2022.100233. eCollection 2022 Dec. Am Heart J Plus. 2022. PMID: 38560633 Free PMC article.
-
Predictive Factors of Cardiac Mortality Following TEER in Patients with Secondary Mitral Regurgitation.J Clin Med. 2024 Feb 1;13(3):851. doi: 10.3390/jcm13030851. J Clin Med. 2024. PMID: 38337545 Free PMC article.
-
Impairments identified by comprehensive geriatric assessment in potential candidates for left ventricular assist device and heart transplantation.Int J Cardiol Heart Vasc. 2023 Dec 11;50:101318. doi: 10.1016/j.ijcha.2023.101318. eCollection 2024 Feb. Int J Cardiol Heart Vasc. 2023. PMID: 38169976 Free PMC article.
-
Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network.PLoS One. 2023 Nov 28;18(11):e0295016. doi: 10.1371/journal.pone.0295016. eCollection 2023. PLoS One. 2023. PMID: 38015947 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical